11
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Human T-Cell Lymphotropic Virus Type I and Neurological Diseases

&
Pages 228-235 | Published online: 10 Jul 2009

References

  • Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M (1999). Activation of macrophage/microglias with ex-pression of MRP8 and MRP14 is associated with the le-sional activities in the spinal cord lesions in HTLV-I as-sociated myelopathy. J Neurol 246: 358–364.
  • Aye MM, Matsuoka E, Moritoyo T, et al (2000). Histopatho-logical analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the en-tire central nervous system. Acta Neuropathol 100: 245–252.
  • Azimi N, Nagai M, Jacobson S, Waldmann TA (2001). IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci USA 98: 14559–14564.
  • Biddison WE, Kubota R, Kawanishi T, et al (1997). Hu-man T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinfla=atory cytokines, chemokines, and matrix metalloproteinase. J Immunol 159: 2018–2025.
  • Bieganowska K, Hollsberg P, Buckle GJ, et al (1999). Di-rect analysis of viral-specific CD8+ T cells with soluble HLA- A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopa-thy. J Immunol 162: 1765–1771.
  • Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E (2000). Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 82: 1044–1050.
  • Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M (2000). Phylogenetic subgroups of HTLV-I in tax gene and their association with different risk to HTLV-I-associated myelopathy/tropical spastic para-praresis. J Infect Dis 182: 1343–1349.
  • Furuya T, Nakamura T, Shirabe S, et al (1997). Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with hu-man T-lymphotropic virus type I-associated myelopa-thy. Proc Assoc Am Physicians 109: 228–236.
  • Gessain A, Barin F, Vernant JC, et al (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407–410.
  • Goon PK, Hanon E, Igakura T, et al (2002). High frequencies of Th1-type CD4+ T cells specific to HTLV-1 Env and Taxproteins in patients with HTLV-1-associated myelopa-thy/tropical spastic paraparesis. Blood 99: 3335–3341.
  • Grant C, Barmak K, Alefantis T, et al (2002). Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous sys-tem during normal immune surveillance and neuroin-fla=ation. J Cell Physiol 190: 133–159.
  • Greten TF, Slansky JE, Kubota R, et al (1998). Direct visu-alization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci USA 95: 7568–7573.
  • Hanon E, Goon P, Taylor GP, et al (2001). High produc-tion of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood. Blood 98: 721–726.
  • Hanon E, Stinchcombe JC, Saito M, et al (2000). Fratricide among CD8+ T lymphocytes naturally infected with hu-man T cell lymphotropic virus type I. Immunity 13: 657–664.
  • Hara H, Morita M, Iwaki T, et al (1994). Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopa-thy/tropical spastic paraparesis. J Exp Med 180: 831–839.
  • Hausmann S, Biddison VVE, Smith KJ, et al (1999). Pep-tide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures. J Immunol 162: 5389–5397.
  • Izumo S, Ijichi T, Higuchi I, Tashiro A, Takahashi K, Osame M (1992). Neuropathology of HTLV-I-associated myelopathy: a report of two autopsy cases. Acta Paediatr jpn 34: 358–364.
  • Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990). Circulating CD8+ cytotoxic lymphocytes spe-cific for HTLV-I in patients with HTLV-I associated neu-rological disease. Nature 348: 245–248.
  • Jeffery KJ, Siddiqui AA, Bunce M, et al (2000). The influ-ence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I in-fection. J Immuno1165: 7278–7284.
  • Jeffery KJM, Usuku K, Hall SE, et al (1999). HLA alleles de-termine human T-lymphotropic virus-I (HTLV-I) provi-ral load and the risk of HTLV-I-associated myelopathy. Proc Nati Acad Sci USA 96: 3848–3853.
  • Kaplan J, Osame M, Kubota, H (1990). The risk of de-veloping HTLV-I associated myelopathy/tropical spasticparaparesis (HAM/TSP) among persons infected with HTLV-I. J AIDS 3: 1096–1101.
  • Kira J, Fujihara K, Itoyama Y, Goto I, Hasuo K (1991). Leukoencephalopathy in HTLV-I-associated myelopa-thy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neu-rol Sci 106: 41–49.
  • Koenig S, Woods RM, Brewah YA, et al (1993). Charac-terization of MHC class I restricted cytotoxic T cell re-sponses to tax in HTLV-1 infected patients with neuro-logic disease. J Immuno1151: 3874–3883.
  • Kubota R, Kawanishi T, Matsubara H, Maims A, Jacobson S (1998). Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopa-thy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 161: 482–488.
  • Kubota R, Osame M, Jacobson S (2000). Retrovirus: hu-man T-cell lymphotropic virus type I-associated dis-eases and immune dysfunction. In: Effects of microbes on the immune system. Cunningham MW, Fujinami RS (eds). Philadelphia: Lippincott Williams & Wilkins, pp 349–371.
  • Kubota R, Umehara F, Izumo S, et al (1994). HTLV-I provi-ral DNA amount correlates with infiltrating CD4+ lym-phocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 53: 23–29.
  • Lehky TJ, Flerlage N, Katz D, et al (1996). Human T-cell lymphotropic virus type II-associated myelopathy: clin-ical and immunologic profiles. Ann Neurol 40: 714–723.
  • Lehky TJ, Fox CH, Koenig S, et al (1995). Detection of hu-man T-lymphotropic virus type I (HTLV-I) tax mRNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 37: 167–175.
  • Levin MC, Krichavsky M, Berk J, et al (1998). Neuronal molecular mimicry in immune-mediated neurologic dis-ease. Ann Neurol 44: 87–98.
  • Levin MC, Lee SM, Kalume F, et al (2002). Autoi=unity due to molecular mimicry as a cause of neurological dis-ease. Nat Med 8: 509–513.
  • Makino M, Shimokubo S, Wakamatsu SI, Izumo S, Baba M (1999). The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic para-paresis. J Virol 73: 4575–4581.
  • Matsuoka, E, Takenouchi H, Hashimoto K, et al (1998). Perivascular T-cells are infected with HTLV-I in the spinal cord lesions with HAM/TSP: double staining of immunohistochemistry and PCR in situ hybridization. Acta Neuorpathol 96: 340–346.
  • Matsuoka E, Usuku K, Jonosono M, Takenouchi N, Izumo S, Osame M (2000). CD44 splice variant involvement in the chronic inflammatory disease of the spinal cord: HAM/TSP. J Neuroimmunol 102: 1–7.
  • Mor F, Cohen IR (1992). T cells in the lesion of experi-mental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J Clin Invest 90: 2447–2455.
  • Moritoyo T, Reinhart TA, Moritoyo H, et al (1996). Hu-man T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 40: 84–90.
  • Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S (2001a). CD8+ T cells are an in vivo reservoir forhuman T-cell lymphotropic virus type I. Blood 98: 1858–1861.
  • Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S (2001b). Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 183: 197–205.
  • Nagai M, Usuku K, Matsumoto W, et al (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 4: 586–593.
  • Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S (2001c). Increased HTLV-I proviral load and preferen-tial expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 50: 807–812.
  • Nagai M, Yashiki S, Fujiyoshi T, et al (1996). Characteri-zation of a unique T-cell clone established from a pa-tient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens. J Neuroimmunol 65: 97–105.
  • Nakamura T, Furuya T, Nishiura Y, Ichinose K, Shirabe S, Eguchi K (2000). Importance of immune deviation to-ward Th1 in the early immunopathogenesis of human T-lymphotropic virus type I-associated myelopathy. Med Hypotheses 54: 777–782.
  • Osame M, Usuku K, Izumo S, et al (1986). HTLV-I associ-ated myelopathy, a new clinical entity [letter]. Lancet 1: 1031–1032.
  • Parker CE, Nightingale S, Taylor GP, Weber J, Bangham CR (1994). Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected peo-ple, with and without tropical spastic paraparesis, recog-nize multiple epitopes simultaneously. J Virol 68: 2860–2868.
  • Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG (1990). In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 64: 5682–5687.
  • Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S (2001). In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells. Blood 98: 1506–1511.
  • Silva EA, Otsuki K, Leite AC, et al (2002). HTLV-II infec-tion associated with a chronic neurodegenerative dis-ease: clinical and molecular analysis. J Med Virol 66: 253–257.
  • Szymocha R, Akaoka H, Dutuit M, et al (2000). Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J Virol 74: 6433–6441.
  • Umehara F, Abe M, Koeeda Y, Izumo S, Osame M (2000). Axonal damage revealed by accumulation of /3-amyloid precursor protein in HTLV-I-associated myelopathy. J Neurol Sci 176: 95–101.
  • Umehara F, Izumo S, Nakagawa M, eta] (1993). Immunocy-tochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neu-ropathol Exp Neurol 52: 424–430.
  • Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Osame M (1994a). Cytokine expression in the spinal cord lesionsin HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 53: 72–77.
  • Umehara F, Izumo S, Takeya M, Sato E, Osame M (1996). Ex-pression of adhesion molecules and monocyte chemoat-tractant protein-1(MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol 91: 343–350.
  • Umehara F, Nakamura A, Izumo S, et al (1994b). Apoptosis of T-lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to con-trol viral infection in the central nervous system. J Neu-ropathol Exp Neurol 53: 617–624.
  • Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M (1998). Expression of matrix metallopro-teinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 57: 839–849.
  • Usuku K, Sonoda S, Osame M, et al (1988). HLA haplotype-linked high immune responsiveness against HTLV-I inHTLV-I—associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 23: S143—S150.
  • Vine AM, Witkover AD, Lloyd AL, et al (2002). Poly-genic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 186: 932–939.
  • Yamano Y, Nagai M, Brennan M, et al (2001). Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-I-associated myelpa-thy (HAM/TSP). Blood 99: 88–94.
  • Yashiki S, Fujiyoshi T, Arima N, et al (2001). HLA-A26, HLA-B4002, HLA-B4006, and HLA-B4801 alleles predispose to adult T cell leukemia: the limited recog-nition of HTLV type I tax peptide anchor motifs and epi-topes to generate anti-HTLV type 1 tax CD8(±) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 17: 1047–1061.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.